Literature DB >> 18219313

NLRX1 is a mitochondrial NOD-like receptor that amplifies NF-kappaB and JNK pathways by inducing reactive oxygen species production.

Ivan Tattoli1, Leticia A Carneiro, Muguette Jéhanno, Joao G Magalhaes, Youmin Shu, Dana J Philpott, Damien Arnoult, Stephen E Girardin.   

Abstract

NOD-like receptors (NLRs) are a family of intracellular sensors of microbial- or danger-associated molecular patterns. Here, we report the identification of NLRX1, which is a new member of the NLR family that localizes to the mitochondria. NLRX1 alone failed to trigger most of the common signalling pathways, including nuclear factor-kappaB (NF)-kappaB- and type I interferon-dependent cascades, but could potently trigger the generation of reactive oxygen species (ROS). Importantly, NLRX1 synergistically potentiated ROS production induced by tumour necrosis factor alpha, Shigella infection and double-stranded RNA, resulting in amplified NF-kappaB-dependent and JUN amino-terminal kinases-dependent signalling. Together, these results identify NLRX1 as a NLR that contributes to the link between ROS generation at the mitochondria and innate immune responses.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18219313      PMCID: PMC2267388          DOI: 10.1038/sj.embor.7401161

Source DB:  PubMed          Journal:  EMBO Rep        ISSN: 1469-221X            Impact factor:   8.807


  11 in total

Review 1.  Toll-like receptor signalling.

Authors:  Shizuo Akira; Kiyoshi Takeda
Journal:  Nat Rev Immunol       Date:  2004-07       Impact factor: 53.106

Review 2.  Intracellular pattern recognition receptors in the host response.

Authors:  Etienne Meylan; Jürg Tschopp; Michael Karin
Journal:  Nature       Date:  2006-07-06       Impact factor: 49.962

Review 3.  Nod-like proteins in immunity, inflammation and disease.

Authors:  Jörg H Fritz; Richard L Ferrero; Dana J Philpott; Stephen E Girardin
Journal:  Nat Immunol       Date:  2006-12       Impact factor: 25.606

Review 4.  NF-kappaB activation by reactive oxygen species: fifteen years later.

Authors:  Geoffrey Gloire; Sylvie Legrand-Poels; Jacques Piette
Journal:  Biochem Pharmacol       Date:  2006-04-27       Impact factor: 5.858

5.  A direct interaction between JNK1 and CrkII is critical for Rac1-induced JNK activation.

Authors:  S E Girardin; M Yaniv
Journal:  EMBO J       Date:  2001-07-02       Impact factor: 11.598

6.  CARD4/Nod1 mediates NF-kappaB and JNK activation by invasive Shigella flexneri.

Authors:  S E Girardin; R Tournebize; M Mavris; A L Page; X Li; G R Stark; J Bertin; P S DiStefano; M Yaniv; P J Sansonetti; D J Philpott
Journal:  EMBO Rep       Date:  2001-07-19       Impact factor: 8.807

Review 7.  Cell death by necrosis: towards a molecular definition.

Authors:  Pierre Golstein; Guido Kroemer
Journal:  Trends Biochem Sci       Date:  2006-12-01       Impact factor: 13.807

8.  Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3.

Authors:  Rashu B Seth; Lijun Sun; Chee-Kwee Ea; Zhijian J Chen
Journal:  Cell       Date:  2005-09-09       Impact factor: 41.582

9.  ASC is a Bax adaptor and regulates the p53-Bax mitochondrial apoptosis pathway.

Authors:  Takao Ohtsuka; Hoon Ryu; Yohji A Minamishima; Salvador Macip; Junji Sagara; Keiichi I Nakayama; Stuart A Aaronson; Sam W Lee
Journal:  Nat Cell Biol       Date:  2004-01-18       Impact factor: 28.824

10.  Nod1 detects a unique muropeptide from gram-negative bacterial peptidoglycan.

Authors:  Stephen E Girardin; Ivo G Boneca; Leticia A M Carneiro; Aude Antignac; Muguette Jéhanno; Jérôme Viala; Karsten Tedin; Muhamed-Kheir Taha; Agnes Labigne; Ulrich Zähringer; Anthony J Coyle; Peter S DiStefano; John Bertin; Philippe J Sansonetti; Dana J Philpott
Journal:  Science       Date:  2003-06-06       Impact factor: 47.728

View more
  140 in total

1.  Function of GRIM-19, a mitochondrial respiratory chain complex I protein, in innate immunity.

Authors:  Yong Chen; Hao Lu; Qian Liu; Guochang Huang; Cheh Peng Lim; Lianhui Zhang; Aijun Hao; Xinmin Cao
Journal:  J Biol Chem       Date:  2012-06-04       Impact factor: 5.157

2.  The inflammasome: in memory of Dr. Jurg Tschopp.

Authors:  M Dagenais; A Skeldon; M Saleh
Journal:  Cell Death Differ       Date:  2011-11-11       Impact factor: 15.828

Review 3.  Shigella: a model of virulence regulation in vivo.

Authors:  Benoit Marteyn; Anastasia Gazi; Philippe Sansonetti
Journal:  Gut Microbes       Date:  2012-03-01

Review 4.  Mitochondria and cell signalling.

Authors:  Stephen W G Tait; Douglas R Green
Journal:  J Cell Sci       Date:  2012-02-15       Impact factor: 5.285

Review 5.  Effector functions of NLRs in the intestine: innate sensing, cell death, and disease.

Authors:  Garabet Yeretssian
Journal:  Immunol Res       Date:  2012-12       Impact factor: 2.829

6.  Post-transcriptional inhibition of luciferase reporter assays by the Nod-like receptor proteins NLRX1 and NLRC3.

Authors:  Arthur Ling; Fraser Soares; David O Croitoru; Ivan Tattoli; Leticia A M Carneiro; Michele Boniotto; Szilvia Benko; Dana J Philpott; Stephen E Girardin
Journal:  J Biol Chem       Date:  2012-06-20       Impact factor: 5.157

7.  Adenovirus type 5 rupture of lysosomes leads to cathepsin B-dependent mitochondrial stress and production of reactive oxygen species.

Authors:  Kathleen A McGuire; Arlene U Barlan; Tina M Griffin; Christopher M Wiethoff
Journal:  J Virol       Date:  2011-08-10       Impact factor: 5.103

Review 8.  Emerging significance of NLRs in inflammatory bowel disease.

Authors:  Beckley K Davis; Casandra Philipson; Raquel Hontecillas; Kristin Eden; Josep Bassaganya-Riera; Irving C Allen
Journal:  Inflamm Bowel Dis       Date:  2014-12       Impact factor: 5.325

9.  NLRX1: friend or foe?

Authors:  Etienne Meylan; Jürg Tschopp
Journal:  EMBO Rep       Date:  2008-03       Impact factor: 8.807

Review 10.  Inflammasomes and its importance in viral infections.

Authors:  Gaurav Shrivastava; Moisés León-Juárez; Julio García-Cordero; David Eduardo Meza-Sánchez; Leticia Cedillo-Barrón
Journal:  Immunol Res       Date:  2016-12       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.